[["the BRAF inhibitor vemurafenib", "may induce", "partial responses and stable disease in patients with papillary thyroid cancer"], ["papillary thyroid cancer", "has become", "refractory to radioactive iodine"], ["vemurafenib", "led to", "a variety of serious adverse events in roughly 65% of patients"], ["serious adverse events", "include", "the development of some squamous cell carcinomas"]]